Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities

CSF and urine biogenic amine metabolites in Rett syndrome

(2010) Annika Lekman et al.   CLINICAL GENETICS

Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus

(2009) Shay Ben-Shachar et al.   HUMAN MOLECULAR GENETICS

Pathophysiology of Locus Ceruleus Neurons in a Mouse Model of Rett Syndrome

(2009) P. Taneja et al.   JOURNAL OF NEUROSCIENCE

Transgenic Mice Lacking Serotonin Neurons Have Severe Apnea and High Mortality during Development

(2009) M. R. Hodges et al.   JOURNAL OF NEUROSCIENCE

Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology

(2009) Nurit Ballas et al.   NATURE NEUROSCIENCE

Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation

(2009) Nadia P. Belichenko et al.   NEUROBIOLOGY OF DISEASE

Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety

(2009) Alexia Thomas et al.   PSYCHOPHARMACOLOGY

Breathing disorders in Rett syndrome: Progressive neurochemical dysfunction in the respiratory network after birth

(2009) David M. Katz et al.   RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY

The hyperactive syndrome: Metanalysis of genetic alterations, pharmacological treatments and brain lesions which increase locomotor activity

(2008) Davide Viggiano   BEHAVIOURAL BRAIN RESEARCH

Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment

(2008) T. Temudo et al.   BRAIN & DEVELOPMENT

Clinical Utility of Monoamine Neurotransmitter Metabolite Analysis in Cerebrospinal Fluid

(2008) K. Hyland   CLINICAL CHEMISTRY

A partial loss of function allele of Methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome

(2008) R. C. Samaco et al.   HUMAN MOLECULAR GENETICS

Movement disorders in Rett syndrome: An analysis of 60 patients with detected MECP2 mutation and correlation with mutation type

(2008) Teresa Temudo et al.   MOVEMENT DISORDERS

The history of dopamine and levodopa in the treatment of Parkinson's disease

(2008) Stanley Fahn   MOVEMENT DISORDERS

Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome

(2008) J. L. Neul et al.   NEUROLOGY

Investigating genotype-phenotype relationships in Rett syndrome using an international data set

(2008) A. Bebbington et al.   NEUROLOGY

Deletion of Mecp2 in Sim1-Expressing Neurons Reveals a Critical Role for MeCP2 in Feeding Behavior, Aggression, and the Response to Stress

(2008) Sharyl L. Fyffe et al.   NEURON

MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription

(2008) M. Chahrour et al.   SCIENCE